Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
TJX delivered strong Q1 FY2027 profitability growth, with net sales up 9% to $14.3B, diluted EPS up 29% to $1.19, and a 1.8-percentage-point improvement in its cost-of-sales ratio, while tariff-refund uncertainty and elevated capital spending remain notable considerations. Source: 10-Q Item 2 MD&A, p.22-24, 29-30
Cost of Revenue
$9.84B
+6.46% YoY
EPS (Diluted)
$1.19
+29.35% YoY
Source: SEC XBRL
Tjx (TJX) reported Q1 FY2027 revenue of $9.84B, up 6.5% year over year. Operating cash flow was $1.12B, up 184.0% year over year. TJX's fiscal Q1 FY2027 corresponds to calendar Q2 2026.
Last 4 quarters: 4 beats
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026This filing | 1.19 | 1.03 | Beat +15.9% |
| Mar 2026 | 1.43 | 1.40 | Beat +1.9% |
| Dec 2025 | 1.28 | 1.23 | Beat +3.7% |
| Sep 2025 | 1.10 | 1.02 | Beat +7.5% |
Reported EPS of $1.19 versus the $1.03 analyst consensus — a +15.9% beat for Jun 2026.
Compiled by AI from 10-Q Item 2 of this filing
Net sales increased 9% year over year to $14.3B, driven by a 6% consolidated comparable-sales increase, 2% growth from non-comparable sales, and a 1% favorable foreign-currency impact. Management said comp growth reflected both a higher average basket and increased customer transactions; store count and selling square footage each grew approximately 3%.
Source: 10-Q Item 2 MD&A
The cost-of-sales ratio declined 1.8 percentage points to 68.7%, which lifted gross margin to 31.3% from 29.5%. Management attributed the improvement to higher markon, favorable year-over-year mark-to-market effects from inventory and fuel hedges, and expense leverage on higher comparable sales; the SG&A ratio rose modestly to 19.5% from 19.4%.
Source: 10-Q Item 2 MD&A
HomeGoods sales rose 11% to $2.5B, including 9% comparable-sales growth, while segment profit margin expanded to 12.9% from 10.2%. Management cited favorable merchandise margin, higher-sales expense leverage, and lower supply-chain and store costs, partly offset by higher markdowns.
Source: 10-Q Item 2 MD&A
Marmaxx reported $8.7B of sales and a 14.7% segment margin, TJX Canada reported $1.3B and an 11.7% margin, and TJX International reported $1.9B and a 4.6% margin. TJX International's 13% sales increase included a 6% favorable foreign-currency effect, while its margin improvement was partly offset by incremental store wages and higher markdowns.
Source: 10-Q Item 2 MD&A
TJX expects fiscal 2027 capital spending of approximately $2.2B-$2.3B and plans to repurchase approximately $2.75B-$3.0B of common stock; $3.5B remained authorized for repurchases at May 2, 2026. The company estimates it paid approximately $490M of IEEPA-related tariffs, has not recorded a refund receivable, and says the amount, timing, and likelihood of recovery remain uncertain.
Source: 10-Q Item 2 MD&A
Compiled by AI from this SEC filing · 0 high, 2 medium, 2 low
TJX's current ratio was 1.14x, based on $14.6B of current assets and $12.9B of current liabilities. Current liabilities grew 18.7% year over year, faster than the 16.2% increase in current assets, which indicates a modestly tighter short-term coverage position despite a ratio above 1.0x.
Source: 10-Q Balance Sheet (XBRL), p.N/A
Operating cash flow increased to $1.1B from $394M, but management states that the $725M increase was partly caused by lower prepaid expenses and other current assets related to receipt of a credit-card interchange-fee settlement. Therefore, the reported 184.0% year-over-year cash-flow growth may not fully represent recurring operating-cash generation.
Source: 10-Q Cash Flow Statement (XBRL), p.N/A
Investing cash outflow was $673M, primarily reflecting capital expenditures, compared with $1.1B of operating cash flow. This leaves approximately $446M of cash flow after investing activities before financing outflows; this is a cash-flow proxy rather than reported free cash flow because investing cash flow is not identical to capital expenditures.
Source: 10-Q Cash Flow Statement (XBRL), p.N/A
Financing activities used $1.1B of cash in Q1 FY2027, including $604M of share repurchases. While cash and equivalents increased to $5.6B and long-term debt declined to $1.9B, continued sizable distributions can reduce financial flexibility if operating cash flow weakens or investment needs rise.
Source: 10-Q Cash Flow Statement and Balance Sheet (XBRL), p.N/A
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Cost of Revenue $B | 9.84 $B | 9.25 $B | +6.46% |
Net Income $B | 1.33 $B | 1.04 $B | +28.57% |
EPS (Basic) $ | 1.20 $ | 0.93 $ | +29.03% |
EPS (Diluted) $ | 1.19 $ | 0.92 $ | +29.35% |
SG&A Expense $B | 2.79 $B | 2.55 $B | +9.61% |
Answers draw on this SEC filing and the data on this page
Expected release date, analyst estimates & what to watch
Other companies in Apparel Retail